Russell Investments Group Ltd. reduced its stake in Kenvue Inc. (NYSE:KVUE – Free Report) by 9.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,134,521 shares of the company’s stock after selling 119,204 shares during the quarter. Russell Investments Group Ltd.’s holdings in Kenvue were worth $20,041,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Eurizon Capital SGR S.p.A. increased its position in Kenvue by 272.7% during the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 867,187 shares of the company’s stock valued at $15,316,000 after purchasing an additional 634,493 shares during the period. Maryland State Retirement & Pension System raised its holdings in Kenvue by 16.3% during the 3rd quarter. Maryland State Retirement & Pension System now owns 115,925 shares of the company’s stock worth $2,047,000 after purchasing an additional 16,259 shares during the last quarter. First Command Advisory Services Inc. lifted its position in shares of Kenvue by 238.6% in the 3rd quarter. First Command Advisory Services Inc. now owns 8,767 shares of the company’s stock worth $157,000 after purchasing an additional 6,178 shares during the period. New York Life Investment Management LLC lifted its position in shares of Kenvue by 2.4% in the 3rd quarter. New York Life Investment Management LLC now owns 702,125 shares of the company’s stock worth $12,400,000 after purchasing an additional 16,254 shares during the period. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Kenvue by 5.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 92,926 shares of the company’s stock worth $1,600,000 after purchasing an additional 4,578 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Kenvue in a research note on Friday, September 11th. UBS Group lifted their target price on shares of Kenvue from $19.00 to $20.00 and gave the stock a “neutral” rating in a research note on Monday, November 2nd. HSBC lowered their target price on shares of Kenvue from $20.00 to $19.00 and set a “hold” rating for the company in a research note on Monday, August 10th. Finally, Wall Street Zen lowered shares of Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Ten equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $19.29.
View Our Latest Report on KVUE
Kenvue Price Performance
Shares of Kenvue stock opened at $19.31 on Thursday. Kenvue Inc. has a one year low of $14.06 and a one year high of $20.13. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. The stock’s 50-day moving average is $18.51 and its 200 day moving average is $18.31. The firm has a market cap of $37.09 billion, a price-to-earnings ratio of 21.94, a PEG ratio of 1.77 and a beta of 0.48.
Kenvue (NYSE:KVUE – Get Free Report) last released its earnings results on Friday, October 30th. The company reported $0.29 EPS for the quarter, hitting the consensus estimate of $0.29. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.86 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%. The firm’s revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.28 earnings per share. Equities research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current year.
Kenvue Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, October 2nd. Shareholders of record on Monday, September 21st were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date was Monday, September 21st. Kenvue’s dividend payout ratio is presently 95.45%.
About Kenvue
Kenvue Inc. is a consumer health company that develops and sells products for everyday health and personal care. Its portfolio includes over-the-counter medicines, skin and hair care, oral care, wound care, and baby care products. Its well-known brands include Tylenol, Neutrogena, Aveeno, Listerine, Band-Aid, Johnson’s, and Zyrtec. Kenvue organizes its business around Self Care, Skin Health and Beauty, and Essential Health. The company became an independent business in 2023 after Johnson & Johnson completed the separation of its consumer health business.
Read More
- Five stocks we like better than Kenvue
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
